We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




AI Model Provides Real-Time Sepsis Risk Alerts for Improving ICU Patient Survival

By HospiMedica International staff writers
Posted on 27 Mar 2025
Print article
Image: The two-stage transformer-based model is designed to predict ICU sepsis mortality (Photo courtesy of 123RF)
Image: The two-stage transformer-based model is designed to predict ICU sepsis mortality (Photo courtesy of 123RF)

Sepsis is a leading cause of death in intensive care units (ICUs), caused by an overwhelming response to infection in the body. Despite advancements in medical treatment, its in-hospital mortality rate remains alarmingly high, ranging from 20% to 50%. The difficulty lies in identifying sepsis early, as it is a highly dynamic condition, and existing scoring systems such as APACHE-II and SOFA are not specifically designed to track its rapid progression. Although machine learning has shown promise in sepsis prediction, most models fail to account for real-time fluctuations in patient data. This highlights the need for a more advanced predictive system that can continuously learn from incoming clinical data to improve early detection and outcomes for patients.

Researchers from Sichuan University (Chengdu, China) and their collaborators have developed a two-stage transformer-based model aimed at predicting ICU sepsis mortality. The model was trained on data from the eICU Collaborative Research Database, which includes over 200,000 patient records, and processes both hourly and daily health indicators. By day five of ICU admission, the model achieved an impressive AUC of 0.92, significantly outperforming traditional scoring systems like APACHE-II. This AI-driven model represents a major step forward in sepsis prediction. It operates in two stages: the first analyzes hourly data to capture critical intra-day changes in vital signs and lab results, while the second stage incorporates daily data to identify longer-term trends. This dual approach enables the model to adjust to the rapid fluctuations characteristic of sepsis.

The study, published in Precision Clinical Medicine, showed that key mortality predictors—such as lactate levels, respiratory rates, and coagulation markers—were identified with high accuracy. A key innovation of the model is its ability to generate real-time risk alerts, providing ICU teams with actionable insights at the most critical moments. The inclusion of SHAP (SHapley Additive exPlanations) visualizations ensures that the model’s predictions are interpretable, allowing clinicians to understand which factors influence the predictions. Additionally, the model demonstrated robustness when validated on external datasets, including patient cohorts from China and the MIMIC-IV database. This research has the potential to transform ICU management. By integrating the AI model into hospital information systems, clinicians could receive daily risk alerts, enabling earlier and more focused interventions.

The model’s ability to adapt across different patient populations and its resilience to missing data make it a valuable tool in a variety of healthcare settings around the world. Future advancements may see the model incorporated into real-time monitoring systems, continuously updating risk scores and reducing diagnostic delays. Beyond its immediate clinical applications, the model’s interpretability through SHAP analysis provides deeper insights into the progression of sepsis, potentially guiding the development of targeted therapies. This breakthrough not only improves patient care but also sets a new standard for AI-driven predictive models in critical care medicine. With its ability to process vast amounts of real-time data and turn it into life-saving insights, this AI tool has the potential to redefine the standard of care for sepsis patients, enabling timely interventions and improving survival rates on a global scale.

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Patient Monitor
Vista 300
New
Electrocardiograph
BeneHeart R700/R900

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.